CDN1163
Product Specifications
UNSPSC Description
CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders[1].
Target Antigen
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/CDN1163.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=C2N=C(C)C=CC2=CC=C1)C3=CC=C(OC(C)C)C=C3
Molecular Weight
320.39
References & Citations
[1]Kang S, et al. Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders. J Biol Chem. 2016 Mar 4;291(10):5185-98.|[2]Singh R, et al. A role for calcium in resistin transcriptional activation in diabetic hearts. Sci Rep. 2018 Oct 23;8(1):15633.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101455/CDN1163-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101455/CDN1163-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
892711-75-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1074596-01 10 mg
N- (5-Cyclopropyl-1,3,4-oxadiazol-2-yl) -4- ((2-methylpiperidin-1-yl) sulfonyl) benzamide
Ask
View Details 
OR1074596-02 25 mg
N- (5-Cyclopropyl-1,3,4-oxadiazol-2-yl) -4- ((2-methylpiperidin-1-yl) sulfonyl) benzamide
Ask
View Details